Renowned scientist and noted expert on krill and the krill fishery, Dr. Stephen Nicol has joined Aker BioMarine Antarctic's Science Board (ASB). "I am very pleased and honoured to be able to join the ASB. Aker BioMarine Antarctic represents the company that has taken the driving seat in developing a sustainable approach to utilising Antarctic krill in the Southern Ocean. Being a member of ASB, I will be able to participate in a continuous improvement in managing the harvest of this key resource in a sustainable manner," said Dr. Nicol.
Dr. Nicol holds degrees in Zoology, Oceanography, and Biology and worked for over 20 years with the Australian Antarctic Division as a research scientist and Program Leader. He directed four major research voyages to the Antarctic and participated in five additional voyages. His extensive study and research on krill, the krill fishery, and the Southern Ocean ecosystem has led to over 200 published articles including the recently published article in Fish and Fisheries, "The fishery for Antarctic krill-recent developments" which outlined research that led to the determination that the krill fishery remains one of the ocean's largest known underexploited stocks. Dr. Nicol has served on the Australian delegation to the Commission for the Conservation of Antarctic Marine Living Resources since 1987 and in 2011 he was awarded the Australian Antarctic Medal in recognition of service to Australia's Antarctic Program. Currently, Dr. Nicol serves as Adjunct Professor at the Institute for Marine and Antarctic Studies at the University of Tasmania.
"Steve Nicol's years of experience with krill and the krill fishery are remarkable. His study of the changing krill fishery and the impact of increased demand and new harvesting technology will be an invaluable asset in our discussions," says Sigve Nordrum, Sustainability Director for Aker BioMarine. "We are very fortunate to have him participate in the ASB."
The ASB brings together internationally recognized scientific experts who will join with Aker BioMarine Antarctic's staff scientists to discuss the commercial and regulatory landscape for krill phospholipid omega-3s and the global demands for increased omega-3 consumption and supplementation. Given the international scope of Aker BioMarine Antarctic's business, the members of the ASB provide diverse council from many complementary disciplines and combine to offer a global perspective.
Other ASB Board Members include: Dr. Sebastiano Banni, Associate Professor of Physiology at the Faculty of Sciences for the University of Cagliari; Professor Philip Calder, President of the International Society for the Study of Fatty Acids and Lipids (ISSFAL); Dr. Vincenzo Di Marzo, Research Director at the Institute of Biomolecular Chemistry of the National Research Council in Pozzuoli, Naples, Italy; Dr. Tomohito Hamazaki, past president and chair of the board of Japan Society for Lipid Nutrition; Dr. William Harris, PhD in Nutritional Biochemistry from the University of Minnesota, Director of Research and Clinical Trials at Health Diagnostic Laboratory, Inc. (Richmond, VA, USA); Mr. Willem van Nieuwenhuyzen, Ir. (MSc.) degree in Food Science and Technology from Wageningen University (the Netherlands).
The Aker Science Board will provide strategic guidance for ongoing research and development including in vitro, preclinical and clinical studies as well as the development of supplements and products for the food and beverage, cosmetics, and feed categories internationally.
Aker BioMarine Antarctic is the only krill ingredient marketer that is primary in its supply. Aker BioMarine Antarctic's proprietary Eco-Harvesting(TM) technology and on-board processing result in the unique composition of Superba(TM) Krill Oil and provide full traceability from sea to shelf. The Marine Stewardship Council (MSC) has granted MSC Certification to Aker BioMarine Antarctic's fisheries, an exclusive distinction that no other krill fishery has earned. As part of an established commitment to substantiating krill's health benefits, Aker BioMarine Antarctic continues to sponsor in vitro, in vivo, and human clinical trials with phospholipid EPA & DHA from krill oil, consistently demonstrating a higher uptake of phospholipid omega-3 fatty acids, improved blood lipid profiles, and increased uptake of DHA in brain tissue compared to other omega-3 fatty acid sources.
About SuperbaTM Krill Oil
Superba(TM) Krill Oil is a pure, natural source of the health-promoting EPA & DHA omega-3 essential fatty acids and the naturally occurring antioxidant astaxanthin. The uniqueness of Superba(TM) Krill Oil is that the omega-3 fatty acids are provided in phospholipid form. In vitro, in vivo and human clinical research has demonstrated the safety and efficacy of SuperbaTM Krill Oil.
About Aker BioMarine Antarctic
Aker BioMarine Antarctic is an integrated biotechnology company dedicated to the sustainable harvesting of krill and development of krill-derived biotech products. The company supplies biomarine ingredients through an optimized value chain from raw materials to customers. Aker BioMarine Antarctic's SuperbaTM Krill products are provided with 100% traceability from the Antarctic sea to the end user. Only Aker's krill fishery has been awarded Marine Stewardship Council (MSC) Certification.